These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6138662)

  • 21. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies.
    Williams RC
    Clin Exp Rheumatol; 1984; 2(1):3-4. PubMed ID: 6442637
    [No Abstract]   [Full Text] [Related]  

  • 22. The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus.
    Derksen RH; Bouma BN; Kater L
    Scand J Rheumatol; 1987; 16(3):185-92. PubMed ID: 3110945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus patients.
    Derksen RH; Bouma BN; Kater L
    Arthritis Rheum; 1986 May; 29(5):695-6. PubMed ID: 3087369
    [No Abstract]   [Full Text] [Related]  

  • 24. Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension.
    Hardie RJ; Isenberg DA
    Ann Rheum Dis; 1985 Jul; 44(7):491-3. PubMed ID: 3927857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prosser-White oration 1983. Connective tissue disease and the skin.
    Hughes GR
    Clin Exp Dermatol; 1984 Nov; 9(6):535-44. PubMed ID: 6437711
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticardiolipin antibodies and the lupus anticoagulant.
    Ann Intern Med; 1987 Sep; 107(3):431-3. PubMed ID: 3113310
    [No Abstract]   [Full Text] [Related]  

  • 27. Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies.
    Drew P; Asherson RA; Zuk RJ; Goodwin FJ; Hughes GR
    Ann Rheum Dis; 1987 Aug; 46(8):612-6. PubMed ID: 3116955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody to cardiolipin, lupus anticoagulant, and fetal death.
    Lockshin MD; Qamar T; Druzin ML; Goei S
    J Rheumatol; 1987 Apr; 14(2):259-62. PubMed ID: 3110418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-phospholipid antibodies.
    Harris EN; Gharavi AE; Hughes GR
    Clin Rheum Dis; 1985 Dec; 11(3):591-609. PubMed ID: 3935364
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-cardiolipin antibodies and the lupus anticoagulant.
    Harris EN; Hughes GR; Gharavi AE
    Clin Exp Rheumatol; 1986; 4(2):187-90. PubMed ID: 3089659
    [No Abstract]   [Full Text] [Related]  

  • 31. Post partum renal failure in systemic lupus erythematosus associated with circulating lupus anticoagulant and anticardiolipin antibody.
    Kincaid-Smith P
    Clin Nephrol; 1991 Jul; 36(1):52. PubMed ID: 1909612
    [No Abstract]   [Full Text] [Related]  

  • 32. Lupus anticoagulant and anticardiolipin antibodies in pregnancy: a review. I. Immunochemistry and clinical implications.
    Hadi HA; Treadwell EL
    Obstet Gynecol Surv; 1990 Nov; 45(11):780-5. PubMed ID: 2122340
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus.
    Loizou S; Byron MA; Englert HJ; David J; Hughes GR; Walport MJ
    Q J Med; 1988 Jul; 68(255):525-31. PubMed ID: 3252304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence on pregnancy of anti-SSA/Ro antibodies in systemic lupus erythematosus.
    Leu LY; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):12-20. PubMed ID: 1306146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG class anti-cardiolipin antibody as a possible marker for evaluating fetal risk in patients with systemic lupus erythematosus.
    Shimada K; Koike T; Ichikawa K; Tsutsumi A; Takabayashi K; Tomioka H; Yoshida S
    J Autoimmun; 1989 Dec; 2(6):843-9. PubMed ID: 2515869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity.
    Colaço CB; Male DK
    Clin Exp Immunol; 1985 Feb; 59(2):449-56. PubMed ID: 2579756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid antibodies: a review.
    Harris EN; Gharavi AE; Asherson RA; Hughes GR
    Eur J Rheumatol Inflamm; 1984; 7(1):5-8. PubMed ID: 6443722
    [No Abstract]   [Full Text] [Related]  

  • 38. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
    Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F
    BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies in systemic lupus erythematosus.
    Ichikawa Y; Shimizu H; Moriuchi J; Uchiyama M; Takaya M; Arimori S; Kobayashi N; Watanabe K; Kawada T; Tanaka Y
    Tokai J Exp Clin Med; 1990 May; 15(2-3):241-4. PubMed ID: 2130530
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating anticoagulant in systemic lupus erythematosus: clinical manifestations.
    Pauzner R; Rosner E; Many A
    Acta Haematol; 1986; 76(2-3):90-4. PubMed ID: 3101369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.